131 related articles for article (PubMed ID: 8144000)
21. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of diarrhea in inflammatory bowel diseases.
Binder HJ
Ann N Y Acad Sci; 2009 May; 1165():285-93. PubMed ID: 19538318
[TBL] [Abstract][Full Text] [Related]
23. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.
Babyatsky MW; Rossiter G; Podolsky DK
Gastroenterology; 1996 Apr; 110(4):975-84. PubMed ID: 8613031
[TBL] [Abstract][Full Text] [Related]
24. Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease.
Michalski CW; Autschbach F; Selvaggi F; Shi X; Di Mola FF; Roggo A; Müller MW; Di Sebastiano P; Büchler MW; Giese T; Friess H
Am J Surg; 2007 Apr; 193(4):476-81. PubMed ID: 17368292
[TBL] [Abstract][Full Text] [Related]
25. Crohn's disease but not chronic ulcerative colitis induces the expression of PAI-1 in enteric neurons.
Laerum OD; Illemann M; Skarstein A; Helgeland L; Ovrebø K; Danø K; Nielsen BS
Am J Gastroenterol; 2008 Sep; 103(9):2350-8. PubMed ID: 18844621
[TBL] [Abstract][Full Text] [Related]
26. Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel disease.
Peetermans WE; D'Haens GR; Ceuppens JL; Rutgeerts P; Geboes K
Gastroenterology; 1995 Jan; 108(1):75-82. PubMed ID: 7528700
[TBL] [Abstract][Full Text] [Related]
27. Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta.
Reubi JC; Horisberger U; Studer UE; Waser B; Laissue JA
J Clin Endocrinol Metab; 1993 Nov; 77(5):1323-8. PubMed ID: 7915721
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease.
More L; Sim R; Hudson M; Dhillon AP; Pounder R; Wakefield AJ
J Clin Pathol; 1993 Aug; 46(8):703-8. PubMed ID: 8408693
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
[TBL] [Abstract][Full Text] [Related]
30. Somatostatin receptors in the developing rat brain.
Thoss VS; Duc D; Hoyer D
Eur J Pharmacol; 1996 Feb; 297(1-2):145-55. PubMed ID: 8851178
[TBL] [Abstract][Full Text] [Related]
31. Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease.
Stadnicki A; Mazurek U; Plewka D; Wilczok T
Int Immunopharmacol; 2003 Jul; 3(7):939-44. PubMed ID: 12810351
[TBL] [Abstract][Full Text] [Related]
32. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease.
Schürmann GM; Bishop AE; Facer P; Vecchio M; Lee JC; Rampton DS; Polak JM
Gut; 1995 Mar; 36(3):411-8. PubMed ID: 7535284
[TBL] [Abstract][Full Text] [Related]
34. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease.
Souza HS; Elia CC; Spencer J; MacDonald TT
Gut; 1999 Dec; 45(6):856-63. PubMed ID: 10562584
[TBL] [Abstract][Full Text] [Related]
35. High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis.
Murch SH; Braegger CP; Sessa WC; MacDonald TT
Lancet; 1992 Feb; 339(8790):381-5. PubMed ID: 1346658
[TBL] [Abstract][Full Text] [Related]
36. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
37. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
38. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
Zhang W; Teng G; Wu T; Tian Y; Wang H
Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
[TBL] [Abstract][Full Text] [Related]
39. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
40. In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue.
Reubi JC; Waser B; Horisberger U; Krenning E; Lamberts SW; Gebbers JO; Gersbach P; Laissue JA
Blood; 1993 Oct; 82(7):2143-51. PubMed ID: 8400264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
